Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
For full access to this article login to GEN Select now.
GEN's 30th Anniversary: Antisense
- Recent news stories have noted that RNAi technology, once thought so promising among many in the life science community and especially big pharma, is now falling out of favor. The biggest hit took place last November when Roche dropped out of RNAi R&D after plunking down a half a ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.